Jean-Jacques Bienaim
2009
In 2009, Jean-Jacques Bienaim earned a total compensation of $3.8M as Chief Executive Officer at BioMarin Pharmaceutical, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $794,962 |
|---|---|
| Option Awards | $1,821,600 |
| Salary | $739,482 |
| Stock Awards | $460,480 |
| Other | $31,874 |
| Total | $3,848,398 |
Bienaim received $1.8M in option awards, accounting for 47% of the total pay in 2009.
Bienaim also received $795K in non-equity incentive plan, $739.5K in salary, $460.5K in stock awards and $31.9K in other compensation.
Rankings
In 2009, Jean-Jacques Bienaim's compensation ranked 1,081st out of 9,885 executives tracked by ExecPay. In other words, Bienaim earned more than 89.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,081 out of 9,885 | 89th |
Division Manufacturing | 379 out of 3,690 | 90th |
Major group Chemicals And Allied Products | 83 out of 871 | 91st |
Industry group Drugs | 56 out of 643 | 91st |
Industry Pharmaceutical Preparations | 48 out of 446 | 89th |
Source: SEC filing on March 23, 2012.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2009.
2009
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2009
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
2009
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2009
Jeffrey Cooper
BioMarin Pharmaceutical
Chief Financial Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019